Back
Impala Platinum Holdings Ltd. Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
73
IMPUY
Impala Platinum Holdings Ltd.
Last Price:
$14.66
Seasonality Move:
9.95%
Sell
20
NVO
Novo Nordisk A/S
Last Price:
$48.11
Seasonality Move:
4.04%
Buy
73
Impala Platinum Holdings Ltd. (IMPUY)
is a Buy
Is Impala Platinum Holdings Ltd. a Buy, Sell or Hold?
-
The current Impala Platinum Holdings Ltd. [IMPUY] share price is $14.66. The Score for IMPUY is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
IMPUY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $48.09. The Score for NVO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
IMPUY Stock Price Chart
What is Impala Platinum Holdings Ltd.'s stock price today?
-
The Impala Platinum Holdings Ltd. share price today is $14.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMPUY is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $48.09Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
IMPUY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.73 | Buy |
| Relative Strength Index (14 RSI): | 74.6 | Buy |
| Chaikin Money Flow: | 41071 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.33 - 13.65) | Buy |
| Bollinger Bands (100): | (9.87 - 12.75) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 46.95 | Sell |
| Chaikin Money Flow: | -7995446 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.92 - 49.34) | Sell |
| Bollinger Bands (100): | (48.13 - 56.93) | Sell |
IMPUY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.78 | Buy |
| 20-day SMA: | 12.87 | Buy |
| 50-day SMA: | 11.99 | Buy |
| 200-day SMA: | 9.41 | Buy |
| 8-day EMA: | 13.88 | Buy |
| 20-day EMA: | 13.07 | Buy |
| 50-day EMA: | 12.23 | Buy |
| 200-day EMA: | 9.91 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.04 | Sell |
| 20-day SMA: | 48.12 | Sell |
| 50-day SMA: | 50 | Sell |
| 200-day SMA: | 60.88 | Sell |
| 8-day EMA: | 48.42 | Sell |
| 20-day EMA: | 48.52 | Sell |
| 50-day EMA: | 50.22 | Sell |
| 200-day EMA: | 63.1 | Sell |
Impala Platinum Holdings Ltd. Earnings Growth & IMPUY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.16 per share.
Impala Platinum Holdings Ltd. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||